Teligent Announces $140m Operating Loss As Plant Woes Continue

Sales Drop By A Third After Challenging 12 Months

 
• By Dean Rudge
  
Help businessman falls
Teligent has revealed the full impact of the FDA Warning Letter on its operations • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business